Is iShares Core MSCI EAFE ETF undervalued?

iShares Core MSCI EAFE ETF Valuation Overview

Last updated: 01 April 2026

iShares Core MSCI EAFE ETF is an exchange-traded fund providing exposure to Financials, Industrials, Technology. Top holdings include ASML, AZN, NOVN, ROP, HSBA.

Current Valuation

iShares Core MSCI EAFE ETF

Ticker: IEFA
Fair Value 0.2% OVERVALUED
Timing Signal OVERHEATED
Risk Level LOW
Confidence HIGH

The iShares Core MSCI EAFE ETF (IEFA) is currently assessed as slightly overvalued, meaning its price is a bit higher than what analysts believe it should be. The market is showing signs of being overheated, which suggests that prices may have risen too quickly. Overall, this ETF is considered low risk, and there is a high level of confidence in its stability.

Analysis date: 01 April 2026
Indicators only. No investment advice.

Quick overview

The iShares Core MSCI EAFE ETF (IEFA) is currently assessed as slightly overvalued, meaning its price is a bit higher than what analysts believe it should be. The market is showing signs of being overheated, which suggests that prices may have risen too quickly. Overall, this ETF is considered low risk, and there is a high level of confidence in its stability.

What moved the ETF last month?

  • The ETF includes many companies from Europe and Asia, which have been influenced by recent economic trends in those regions.
  • Major holdings like ASML and AstraZeneca have performed well, contributing positively to the ETF's value.
  • The financial sector, which makes up over 11% of the ETF, has seen strong performance, boosting the overall returns.
  • Global interest rates have remained low, which tends to support stock prices and encourage investment.
  • There has been a significant increase in earnings for many companies in the ETF, with some reporting growth rates of over 50%.
  • In short: The ETF's performance was driven by strong earnings from key companies and favorable economic conditions, despite being slightly overvalued.

Why is the ETF valued this way today?

  • The ETF's price-to-earnings ratio is around 23.5, which means investors are paying about $23.50 for every $1 of earnings. This is relatively high compared to historical averages, indicating that investors expect strong future growth.
  • Companies in this ETF have a

Key Metrics

Valuation

Trailing P/E 23.5x
Forward P/E 17.2x
Price/Book 6.3x

Quality

ROE 24.1%
Profit Margin 14.3%

Growth

Revenue Growth 5.4%
Earnings Growth 50.7%

Factor Scores

Value Score -0.04
Quality Score +0.04
Growth Score -0.04

Top Holdings Impact

Ticker Name Weight P/E Score
ASML ASML Holding N.V. - Ne... 2.1% 46.5x -4.3%
AZN AstraZeneca PLC 1.3% 30.1x -4.3%
NOVN NOVN 1.2% N/A +0.0%
ROP Roper Technologies, Inc. 1.2% 24.9x -1.1%
HSBA HSBA 1.2% N/A +0.0%

Valuation History

Coming soon

Line chart: Fair value curve and current valuation curve

Table: Monthly valuation history (fair value %, timing, risk, confidence)